We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Lung Cancer
Center of Excellence
In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Lung Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.
In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Lung Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
marco buso
Dec 10, 2021
Whole brain radiotherapy
No systemic therapy, surveillance imaging
Leoncio Arribas Alpuente
Dec 10, 2021
WBRT plus concomitant boost, without systemic therapy if only had brain metastasis
Jean-Yves Douillard
Feb 11, 2022
This case should be discussed in MDT with a radiation oncologist.
The patient is 75, he has brain metastasis as a single organ site. Based on the number of metastatic lesions, I would favour Whole Brain Radiotherapy. After re-evaluation of the brain and in the absence of disease progression at other sites, in a discussion with the patient, I would suggest no further systemic therapy, surveillance imaging and would wait for documented relapse to start another treatment depending on the clinical presentation.
Apr 23, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Michael
J.
Grant
MD
marco buso
Dec 10, 2021
Leoncio Arribas Alpuente
Dec 10, 2021
Jean-Yves Douillard
Feb 11, 2022
Apr 23, 2024
Pending Moderator approval.